Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

Josep M. Llovet, Joong‐Won Park, Won Young Tak et al.|Journal of Clinical Oncology|2013

Cited by 596